Exenatide better than glimepiride as second option after metformin in type 2 diabetes

mdCurrent Conference Report: 72nd Annual Scientific Sessions of the American Diabetes Association

A recent study found that adding exenatide twice daily is superior to glimepiride once daily to achieve glycemic control in patients with type 2 diabetes who can’t achieve control on metformin.


“These results are important because they highlight the durable glucose-normalizing effects of GLP1 analog therapy, prescribed earlier on in the natural history of diabetes.”
–Sanjay Kalra, DM (AIIMS-Endocrinology), consultant in Endocrinology at Bharti Hospital, Karnal, India


Guntram Schernthaner, MD, reported the findings of the study at the 72nd Annual (2012) Scientific Sessions of the American Diabetes Association, which took place in Philadelphia, Pennsylvania, United States.

“These results are important because they highlight the durable...

Log in or register for free to continue reading
Register Now For Free Already Registered? Log In
This entry was posted in Diabetes, Primary Care and tagged , , , , , , , , . Volume: .

Post a Comment

You must be logged in to post a comment.

  • Follow mdCurrent Health for the latest health news!

    Email Newsletter